-
GSK gains FDA expansion for Blujepa to treat gonorrhea
12 Dec 2025 22:41 GMT
… Preparedness and Response and the Biomedical Advanced Research and Development Authority, GSK said.
Another oral …
-
GSK Blujepa gets USFDA approval as oral option for uncomplicated urogenital gonorrhoea
12 Dec 2025 13:44 GMT
… for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction …
-
FDA Approves First New Oral Antibiotic Class for Gonorrhea in 30+ Years
12 Dec 2025 13:46 GMT
… for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction …
-
Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital gonorrhoea (uGC)
11 Dec 2025 20:57 GMT
… for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction …
-
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
11 Dec 2025 13:46 GMT
… awarded to Ginkgo by the Biomedical Advanced Research and Development Authority (BARDA). The project, funded …
-
DNAe Unveils Early Access Program for LiDia‑SEQ™: Hospital Teams Invited to Trial DNAe's Flagship Tests and Preview DNAe's Innovative NGS Diagnostic Platform
11 Dec 2025 11:59 GMT
… has received funding from The Biomedical Advanced Research and Development Authority (BARDA)** to develop its … Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600017C …
-
Companies are just now tallying the hit from US shutdown
11 Dec 2025 11:34 GMT
… on a contract with the Biomedical Advanced Research and Development Authority because of the shutdown …
-
Eukarÿs Wins 2025 BioTools Innovator Grand Prize and Joins BARDA’s Elite VANGUARD Program
11 Dec 2025 10:00 GMT
… ten were chosen by BARDA (Biomedical Advanced Research and Development Authority) to join its VANGUARD …
-
Investornewsbreaks Soligenix Inc. (NASDAQ: SNGX) Featured In Networknewsaudio APR On Urgent Need For Rare Disease Therapies
11 Dec 2025 06:06 GMT
… Reduction Agency (DTRA) and the Biomedical Advanced Research and Development Authority (BARDA).
NOTE TO INVESTORS …
-
An Upcoming Funding Opportunity and Two National Events: MTEC Prepares for a Big Start to 2026
10 Dec 2025 15:43 GMT
… is collaborating with the Biomedical Advanced Research and Development Authority and the Defense Health Agency …